Skip to content

Multi-parametric MRI in Patients of Bladder Cancer

Knowledge-guided Causal Diagnostic Network for the Detection of Muscle-invasive Bladder Cancer With Single T2-weighted Imaging

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06362330
Enrollment
1000
Registered
2024-04-12
Start date
2021-07-01
Completion date
2024-06-30
Last updated
2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence, Muscle-invasive Bladder Cancer

Brief summary

Accurate preoperative detection of muscle-invasive bladder cancer remains a clinical challenge. The investigators aimed to develop and validate a knowledge-guided causal diagnostic network for the detection of muscle-invasive bladder cancer with multiparametric magnetic resonance imaging(MRI).

Detailed description

Patients who underwent bladder MRI were retrospectively collected at three centers between January 2013 and September 2023. The investigators first constructed a nnUNet to segment causal region where muscle-invasive bladder cancer may occur. Subsequently, the investigators explored a causal network based on a modified ResNet3d-18 by striking a fine balance between nnUNet awareness and a self-supervised learning (SSL) model, which steered model to emulate diagnostic acumen of expert in staging muscle-invasive bladder cancer at MRI. Model was trained in center 1, and independently tested in center 1, center 2 and center 3. Ablation test was performed among all 13 Ablation-Test models using either single or multi-parametric MRI. Benefit was tested in six radiologists using vesical imaging-reporting and data system (VI-RADS) versus network-adjusted VI-RADS.

Interventions

OTHERmagnetic resonance imaging

Patients of bladder cancer underwent multiparameter magnetic resonance imaging before surgery

Sponsors

The First Affiliated Hospital with Nanjing Medical University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Urothelial carcinoma of the bladder confirmed by final histopathology ②Received a standard contrast-enhanced 3.0T mpMRI before surgery ③All tumors within patients included were resected and received pathologic examination separately

Exclusion criteria

①Absence of surgical interventions ②With inadequate image quality or with inadequate pathology for analysis

Design outcomes

Primary

MeasureTime frameDescription
Muscle-invasive bladder cancerone monthThe artificial intelligence diagnosis results, based on preoperative MRI, indicated muscle-invasive bladder cancer. Subsequently, this preoperative diagnosis was compared with the postoperative pathological diagnosis to evaluate the diagnostic performance of the artificial intelligence.
Non-muscle-invasive bladder cancerone monthThe artificial intelligence diagnosis results, based on preoperative MRI, indicated non-muscle-invasive bladder cancer. Subsequently, this preoperative diagnosis was compared with the postoperative pathological diagnosis to evaluate the diagnostic performance of the artificial intelligence.

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026